Total Revenue: $14.9 billion, operational decline of 19% year-over-year. Oncology Revenue: Grew 19% operationally, driven by acquisitions and product launches. Adjusted Gross Margin: Improved by 530 ...
Source LinkTotal Revenue: $14.9 billion, operational decline of 19% year-over-year. Oncology Revenue: Grew 19% operationally, driven by acquisitions and product launches. Adjusted Gross Margin: Improved by 530 ...
Source Link
Comments